Investing

Editor's Top Picks

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form Investing

Large cryptocurrencies fall as Solana tumbles

All large cryptocurrencies were down during morning trading on Friday, with Solana SOLUSD, -5.24% seeing

With restaurant prices likely to drop in 2024, here’s why Yum’s stock may be a better buy than McDonald’s

After pandemic lockdowns in 2020 that shuttered many restaurants, followed by price increases throughout 2022

If Nvidia looked more like Salesforce, it might unlock billions more in cash, analyst says

Nvidia Corp. is raking in billions in cash, but one analyst thinks the chip maker

Boeing and Lockheed’s ULA set to launch first Vulcan rocket, sending private lander to the moon

SpaceX rival United Launch Alliance is making final preparations ahead of the debut launch of

AMC’s stock extends losing streak to five days, hits another record-low close

AMC Entertainment Holdings Inc. extended its losing streak to five days Friday, with the stock

Bitcoin Slumps With ETF Speculation at Fever Pitch

Bitcoin and other cryptocurrencies were falling Friday as the sector remains fixated on the potential

Arena Group shares tumble after interim CEO of Sports Illustrated parent company steps down

Arena Group Holdings Inc., the media company that runs Sports Illustrated and TheStreet, said Friday

Oil futures settle lower after ‘massive’ weekly rise in U.S. oil-product inventories

Oil futures settled lower Thursday, pressured after official U.S. data showed what at least one

Why Red Sea chaos is driving oil buyers ‘into the arms of U.S. shale producers’

Attacks by Iran-backed Houthi rebels on vessels in the Red Sea have led to transport

AlloVir To Cut 95% of Workforce After Discontinuing Trials

By Ben Glickman AlloVir will cut about 95% of its current employee base after scrapping

Applied Therapeutics Shares Sink 30% on AT-001 Trial Results

By Denny Jacob Applied Therapeutics shares sank 30% to $2.67 in after-hours trading on Thursday

Shares of Fusion Pharmaceuticals Rise 7.8% With Study Protocol Aligment Reached

By Ben Glickman Shares of Fusion Pharmaceuticals rose in post-market trading on Thursday after the

Stocks to Watch: Dermata Therapeutics, Applied Therapeutics, Fusion Pharmaceuticals

By Denny Jacob Dermata Therapeutics received a newly issued patent in Japan. Shares more than

Unum Group COO Michael Simonds to Resign

By Ben Glickman Unum Group's Chief Operating Officer Michael Simonds will resign effective Feb. 9

QuantumScape Stock Is Up 50%. Thank Volkswagen.

The electric-vehicle battery start-up QuantumScape is starting the year with a bang. Shares were up